Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity

Transplant Proc. 2001 Nov-Dec;33(7-8):3234-5. doi: 10.1016/s0041-1345(01)02375-2.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Calcineurin Inhibitors*
  • Cholesterol / blood
  • Creatinine / blood
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Graft Survival / drug effects
  • Graft Survival / immunology
  • Hemoglobins / metabolism
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Kidney Transplantation / physiology
  • Male
  • Sirolimus / therapeutic use*
  • Survival Rate
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Transplantation, Homologous
  • Triglycerides / blood

Substances

  • Adrenal Cortex Hormones
  • Calcineurin Inhibitors
  • Hemoglobins
  • Immunosuppressive Agents
  • Triglycerides
  • Cholesterol
  • Creatinine
  • Sirolimus
  • Tacrolimus